Preferred Name |
Hydrocortisone Acetate |
|
Synonyms |
|
|
Definitions |
The synthetic acetate ester form of hydrocortisone, a corticosteroid with anti-inflammatory and immunosuppressive properties. Hydrocortisone acetate initially binds to the cytoplasmic glucocorticoid receptor; then the receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C61785 |
|
CAS_Registry |
50-03-3 |
|
CHEBI_ID |
CHEBI:17609 |
|
Chemical_Formula |
C23H32O6 |
|
code |
C61785 |
|
Contributing_Source |
FDA |
|
definition |
The synthetic acetate ester form of hydrocortisone, a corticosteroid with anti-inflammatory and immunosuppressive properties. Hydrocortisone acetate initially binds to the cytoplasmic glucocorticoid receptor; then the receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes. |
|
FDA_UNII_Code |
3X7931PO74 |
|
in_subset | ||
label |
Hydrocortisone Acetate |
|
Legacy Concept Name |
Hydrocortisone_Acetate |
|
Preferred_Name |
Hydrocortisone Acetate |
|
prefixIRI |
NCIT:C61785 |
|
prefLabel |
Hydrocortisone Acetate |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0063077 |
|
subClassOf |